CollinsworthKAKaimanSMHarrisonDC, The clinical pharmacology of lidocaine as an antiarrhythmic drug. Circulation1974; 50: 1217–30.
2.
StensonREConstantinoRTHarrisonDC, Interrelationships of hepatic blood flow, cardiac output and blood levels of lidocaine in man. Circulation1971; 43: 205–11.
3.
PrescottIFAdjepon-YamoahKKTalbotRG, Impaired lignocaine metabolism in patients with myocardial infarction and cardiac failure. Br Med J1976; 1: 939–41.
4.
ThomsonPDMelmonKLRichardsonJA, Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med1973; 78: 499–508.
5.
ZitoRAReidPR, Lidocaine kinetics predicted by indocyanine green clearance. N Engl J Med1978; 298: 1160–3.
6.
LeLorierJGrenonDLatourY, Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann Intern Med1977; 87: 700–2.
7.
FredrickDSBoersmaRB, Lidocaine infusions: Effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables. Am J Hosp Pharm1979; 36: 778–81.
8.
GianellyRvonder GroebenJOSpivackAPHarrisonDC, Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med1967; 277: 1215–9.
9.
BoudoulasHSchaalSFLewisRPWelchTGDeGreenPKatesRE, Negative inotropic effect of lidocaine in patients with coronary arterial disease and normal subjects. Chest1977; 71: 170–5.
10.
GuptaPKLichsteinEChaddaKD, Lidocaine-induced heart block in patients with bundle branch block. Am J Cardiol1974; 33: 487–92.
11.
PfeiferHJGreenblattDJKoch-WeserJ.Clinical use and toxicity of intravenous lidocaine. Am Heart J1976; 92: 168–73.
12.
BenowitzNLMeisterW.Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet1978; 3: 177–201.
